{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:50:33Z","timestamp":1791409833938,"version":"4.3.3"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["JDC2023-051540-I"],"award-info":[{"award-number":["JDC2023-051540-I"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"publisher","award":["CEX2021-001159-M"],"award-info":[{"award-number":["CEX2021-001159-M"]}],"id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021SGR-00230"],"award-info":[{"award-number":["2021SGR-00230"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021SGR-00453"],"award-info":[{"award-number":["2021SGR-00453"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["FI-SDUR"],"award-info":[{"award-number":["FI-SDUR"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015439","name":"Centres de Recerca de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015439","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110386","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:52:40Z","timestamp":1786805560000},"page":"110386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["cis-\u03b3-Amino-L-proline peptides as chemical probes of amyloidogenic processing in neurons and APP\/PS1 mice"],"prefix":"10.1016","volume":"181","author":[{"given":"Dayaneth","family":"J\u00e1come","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"P\u00e9rez-Palau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Mart\u00ednez-Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Lid\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Carbajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"S\u00e1nchez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Albericio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5292-0819","authenticated-orcid":false,"given":"Miriam","family":"Royo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1982-2162","authenticated-orcid":false,"given":"Rosalina","family":"Gav\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5214-4909","authenticated-orcid":false,"given":"Jos\u00e9 Antonio","family":"Del R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2026.110386_bb0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41582-022-00659-0","article-title":"Rapidly progressive dementias - aetiologies, diagnosis and management","volume":"18","author":"Hermann","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110386_bb0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3233\/JAD-2012-112168","article-title":"Efficient near-infrared in vivo imaging of amyoid-beta deposits in Alzheimer\u2019s disease mouse models","volume":"30","author":"Schmidt","year":"2012","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110386_bb0015","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archneurol.2011.189","article-title":"Rapidly progressive Alzheimer disease","volume":"68","author":"Schmidt","year":"2011","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110386_bb0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-011-0825-z","article-title":"Alzheimer\u2019s pathogenesis: is there neuron-to-neuron propagation?","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110386_bb0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110386_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110386_bb0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2013.12.009","article-title":"Genetic mouse models of brain ageing and Alzheimer\u2019s disease","volume":"142","author":"Bilkei-Gorzo","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110386_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10571-025-01655-w","article-title":"The 3xTg-AD mouse model: a comprehensive tool for understanding Alzheimer\u2019s disease","volume":"46","author":"Pattanayak","year":"2026","journal-title":"Cell. Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110386_bb0045","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110386_bb0050","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/alz.12450","article-title":"The costs of developing treatments for Alzheimer\u2019s disease: a retrospective exploration","volume":"18","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"111","key":"10.1016\/j.bioorg.2026.110386_bb0055","doi-asserted-by":"crossref","first-page":"111cm33","DOI":"10.1126\/scitranslmed.3002609","article-title":"Testing the right target and right drug at the right stage","volume":"3","author":"Sperling","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110386_bb0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110386_bb0065","article-title":"Targeting amyloid pathology in early Alzheimer\u2019s: the promise of Donanemab-Azbt","volume":"13","author":"Khartabil","year":"2025","journal-title":"Pharmacy (Basel)"},{"issue":"10510","key":"10.1016\/j.bioorg.2026.110386_bb0070","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0140-6736(25)01329-7","article-title":"Treatment for Alzheimer's disease","volume":"406","author":"Fox","year":"2025","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110386_bb0075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ncl.2013.03.012","article-title":"Immunotherapy for Alzheimer\u2019s disease","volume":"31","author":"Farlow","year":"2013","journal-title":"Neurol. Clin."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110386_bb0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1474-4422(25)00024-9","article-title":"Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer\u2019s disease: an open-label extension of the phase 2\/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial","volume":"24","author":"Bateman","year":"2025","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110386_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-024-01669-4","article-title":"Post-marketing safety concerns with lecanemab: a pharmacovigilance study based on the FDA adverse event reporting system database","volume":"17","author":"Xing","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"5580","key":"10.1016\/j.bioorg.2026.110386_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110386_bb0095","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1523\/JNEUROSCI.4129-14.2015","article-title":"The potent BACE1 inhibitor LY2886721 elicits robust central Abeta pharmacodynamic responses in mice, dogs, and humans","volume":"35","author":"May","year":"2015","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110386_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0896-6273(03)00810-9","article-title":"BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease","volume":"41","author":"Ohno","year":"2004","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110386_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13195-018-0415-6","article-title":"Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer\u2019s disease: randomized, double-blind, placebo-controlled study","volume":"10","author":"Timmers","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"5 Suppl","key":"10.1016\/j.bioorg.2026.110386_bb0110","first-page":"S411","article-title":"Lessons from a BACE1 inhibitor trial: off-site but not off base","volume":"10","author":"Lahiri","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110386_bb0115","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183677","article-title":"It\u2019s good to know what to BACE the specificity of your inhibitors on","volume":"134","author":"Murray","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"s1","key":"10.1016\/j.bioorg.2026.110386_bb0120","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.3233\/JAD-231258","article-title":"BACE inhibitor clinical trials for Alzheimer\u2019s disease","volume":"101","author":"Watkins","year":"2024","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110386_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-6147(00)01447-4","article-title":"Cell-penetrating peptides","volume":"21","author":"Lindgren","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110386_bb0130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jmr.630","article-title":"A brief introduction to cell-penetrating peptides","volume":"16","author":"Lundberg","year":"2003","journal-title":"J. Mol. Recognit."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110386_bb0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2004.08.019","article-title":"Cationic compounds used in lipoplexes and polyplexes for gene delivery","volume":"100","author":"Zhang","year":"2004","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110386_bb0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrn1104","article-title":"Viral vectors for gene delivery to the nervous system","volume":"4","author":"Davidson","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"15\u201316","key":"10.1016\/j.bioorg.2026.110386_bb0145","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","article-title":"Cell-penetrating peptides: classes, origin, and current landscape","volume":"17","author":"Milletti","year":"2012","journal-title":"Drug Discov. Today"},{"issue":"26","key":"10.1016\/j.bioorg.2026.110386_bb0150","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1021\/ja051648k","article-title":"Cell-penetrating cis-gamma-amino-l-proline-derived peptides","volume":"127","author":"Farrera-Sinfreu","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110386_bb0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.addr.2004.12.001","article-title":"Tat peptide-mediated cellular delivery: back to basics","volume":"57","author":"Brooks","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2026.110386_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejpb.2015.01.028","article-title":"Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders","volume":"91","author":"Egusquiaguirre","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110386_bb0165","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/anie.200352540","article-title":"Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein","volume":"43","author":"Fernandez-Carneado","year":"2004","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110386_bb0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drudis.2014.09.017","article-title":"Therapeutic applications of the cell-penetrating HIV-1 Tat peptide","volume":"20","author":"Rizzuti","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"43","key":"10.1016\/j.bioorg.2026.110386_bb0175","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1039\/c2cc17937g","article-title":"Efficient gamma-amino-proline-derived cell penetrating peptide-superparamagnetic iron oxide nanoparticle conjugates via aniline-catalyzed oxime chemistry as bimodal imaging nanoagents","volume":"48","author":"Cavalli","year":"2012","journal-title":"Chem. Commun. (Camb.)"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110386_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","article-title":"Co-expression of multiple transgenes in mouse CNS: a comparison of strategies","volume":"17","author":"Jankowsky","year":"2001","journal-title":"Biomol. Eng."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110386_bb0185","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s12035-014-8793-7","article-title":"Role of PrPC expression in tau protein levels and phosphorylation in Alzheimer\u2019s disease evolution","volume":"51","author":"Vergara","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110386_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099733","article-title":"A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells","volume":"9","author":"Cecchelli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.110386_bb0195","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cbpa.2017.04.019","article-title":"Blood-brain barrier peptide shuttles","volume":"38","author":"Sanchez-Navarro","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"17","key":"10.1016\/j.bioorg.2026.110386_bb0200","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1039\/C6CS00076B","article-title":"Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery","volume":"45","author":"Oller-Salvia","year":"2016","journal-title":"Chem. Soc. Rev."},{"issue":"38","key":"10.1016\/j.bioorg.2026.110386_bb0205","doi-asserted-by":"crossref","first-page":"26070","DOI":"10.1074\/jbc.M109.013474","article-title":"PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis","volume":"284","author":"Selvaraj","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110386_bb0210","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"17","key":"10.1016\/j.bioorg.2026.110386_bb0215","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1091\/mbc.e11-04-0321","article-title":"Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6\/7-PSD-95 binding","volume":"22","author":"Carulla","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bioorg.2026.110386_bb0220","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fnbeh.2018.00201","article-title":"MouBeAT: a new and open toolbox for guided analysis of behavioral tests in mice","volume":"12","author":"Bello-Arroyo","year":"2018","journal-title":"Front. Behav. Neurosci."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110386_bb0225","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/j.1471-4159.2010.06726.x","article-title":"Neurites regrowth of cortical neurons by GSK3beta inhibition independently of Nogo receptor 1","volume":"113","author":"Seira","year":"2010","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110386_bb0230","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","article-title":"Alzheimer\u2019s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"3","author":"Selkoe","year":"2001","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110386_bb0235","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrd2368","article-title":"Modelling of the blood-brain barrier in drug discovery and development","volume":"6","author":"Cecchelli","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110386_bb0240","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/bip.22257","article-title":"From venoms to BBB shuttles: synthesis and blood-brain barrier transport assessment of apamin and a nontoxic analog","volume":"100","author":"Oller-Salvia","year":"2013","journal-title":"Biopolymers"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110386_bb0245","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1016\/j.bmcl.2011.09.035","article-title":"Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors","volume":"21","author":"Mortensen","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110386_bb0250","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-013-9398-z","article-title":"Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer\u2019s disease","volume":"24","author":"Parsons","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bioorg.2026.110386_bb0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2014.10.025","article-title":"Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents","volume":"285","author":"Grayson","year":"2015","journal-title":"Behav. Brain Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:03:53Z","timestamp":1791407033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S0045206826009223"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110386","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"cis-\u03b3-Amino-L-proline peptides as chemical probes of amyloidogenic processing in neurons and APP\/PS1 mice","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110386"}}